Clinical Trial Update: Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study

View source ↗

Summary

This completed trial investigated seroconversion phenotypes after COVID-19 vaccination in patients with end-stage kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease

Snippet

Sponsor: University of Leicester | Conditions: End Stage Kidney Disease | Status: COMPLETED | Results posted: 2024-09-26